Literature DB >> 21227764

[Rejection of kidney graft: mechanism and prevention].

Chehrazade Brick1, Ouafa Atouf, Nadia Benseffaj, Malika Essakalli.   

Abstract

Rejection occurs after the introduction of a genetically different graft, in a recipient. Nowadays, it is still a major obstacle in renal transplantation and reflects a normal protective immune response of a recipient against a foreign antigen. Involving many mechanisms of the innate and adaptive immunity, this reaction results in renal parenchymal lesions witch may progress to graft destruction and loss of its function. Several ways are currently used to reduce the action of the immune system and consequently reduce the risk of rejection. After a presentation of the main actors and the sequence of events leading to rejection, we will describe the strategy used by antirejection teams' transplantation. We will successively consider the prevention (pre-transplant immunological assessment, preventive immunosuppressive therapy), the monitoring (search for antibodies, biopsies) and the treatment.
Copyright © 2010 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21227764     DOI: 10.1016/j.nephro.2010.10.002

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  5 in total

1.  Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay.

Authors:  Yu Nobuoka; Shugo Mizuno; Kouhei Nishikawa; Kaname Nakatani; Yuichi Muraki; Tomomi Yamada; Masahiro Okuda; Tsutomu Nobori; Yoshiki Sugimura; Shuji Isaji
Journal:  Clin Dev Immunol       Date:  2013-12-25

2.  Clinical relevance of a CD4+ T cell immune function assay in the diagnosis of infection in pediatric living-donor liver transplantation.

Authors:  Wei Liu; Kai Wang; Yi-He Zhao; Guang-Ping Song; Wei Gao; Dai-Hong Li
Journal:  Exp Ther Med       Date:  2019-09-13       Impact factor: 2.447

3.  Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity.

Authors:  Shugo Mizuno; Yuichi Muraki; Kaname Nakatani; Akihiro Tanemura; Naohisa Kuriyama; Ichiro Ohsawa; Yoshinori Azumi; Masashi Kishiwada; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Norihiko Yamamoto; Tomomi Yamada; Katsuya Shiraki; Yoshiyuki Takei; Tsutomu Nobori; Masahiro Okuda; Shuji Isaji
Journal:  Clin Dev Immunol       Date:  2013-09-26

4.  Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients.

Authors:  Tara K Sigdel; Minnie M Sarwal
Journal:  Front Med (Lausanne)       Date:  2017-06-16

5.  Peripheral blood CD4(+) cell ATP activity measurement to predict HCC recurrence post-DCD liver transplant.

Authors:  W Zhang; H Zhong; L Zhuang; J Yu; X Xu; W Wang; M Zhang; L Zhou; S Zheng
Journal:  Int J Clin Pract       Date:  2016-06       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.